BioSpace News Archive

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present at the Wolfe Research Healthcare Conference on November 6 at 10:30 a.m. ET in New York City.

There are more than 134,000 respiratory therapists in the U.S. Respiratory therapists work closely as part of medical teams to evaluate, treat and care for patients with breathing or other cardiopulmonary disorders.

Transaction Bolsters Carlisle’s Presence in Attractive Medical Device Segment

Assistance for UnitedHealthcare plan participants whose access to care or prescriptions needs may have been affected

The market will accelerate at a CAGR of over 8% between 2019-2023

Aradigm Corporation announced that following a recent Oral Explanation, it has received feedback that a negative opinion is likely to be received in November 2019 from the CHMP, a committee of the European Medicines Agency, for the centralized marketing authorization application for Linhaliq as a treatment for non-cystic fibrosis bronchiectasis patients with chronic lung infections with Pseudomonas aeruginosa

One grade is available (R&D-grade) in lot sizes from 1g to 5g.

Amplify, a publisher of next-generation curriculum and assessment programs, announced today that Louisiana rated Amplify Science K–5 as Tier 1, the top rating in the state. Amplify Science is the only K–5 science program in the state to receive a Tier 1 rating

Teva Pharmaceutical Industries Ltd. and its affiliates today announced a settlement agreement with both Cuyahoga and Summit counties of Ohio. The settlement resolves the counties’ claims and removes Teva from the Track 1 opioid litigation.

Health Canada is advising Canadians that the following products may pose serious health risks.